


Bavencio Injection
Written By Dr. Nikita Saini, MBA, MDS,
Reviewed By Dr. Dheeraj Kumar Sharma, PhD, M.Pharm,
Last updated on 26 Oct 2026 | 01:04 AM (IST)
Save more with additional offers







General Information



Product introduction
Bavencio Injection is given as an intravenous infusion by a healthcare professional. It is usually administered once every two weeks, and treatment is continued as long as it is effective and well-tolerated. Do not stop receiving this medicine without consulting your doctor.
Some common side effects of this medicine include fatigue, nausea, diarrhea, decreased appetite, and muscle or joint pain. Some side effects may be mild, while others can be serious and require medical attention. Inform your doctor if any side effects persist, worsen, or if you experience any unusual symptoms.
Before receiving this medicine, inform your doctor if you have a history of allergic reactions, autoimmune disorders, or problems with your heart, kidneys, liver, or thyroid gland. Also, tell your doctor about all the medicines you are taking, including prescription medicines, over-the-counter medicines, and supplements.
Bavencio Injection may harm an unborn baby and should not be used during pregnancy unless your doctor determines it is necessary. Women who can become pregnant should use effective contraception during treatment and for at least one month after the last dose. Breastfeeding is not recommended during treatment and for at least one month after the last dose.
There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.
Uses of Bavencio Injection
Benefits of Bavencio Injection
Bavencio Injection helps to treat urinary bladder cancer (urothelial carcinoma). It kills the cancer cells by stimulating the immune system of our body. It prevents progression of the disease to advanced stages of cancer and also reduces the chances of recurrence of the cancer. It is given as an injection by a doctor or nurse and should not be self-administered.
Kidney cancer (renal cell carcinoma) is a type of kidney cancer that develops in the cells of the kidney and may spread to other parts of the body. Bavencio Injection is used in combination with axitinib to treat advanced renal cell carcinoma. It helps the immune system recognize and attack cancer cells, thereby helping control tumor growth. This helps delay disease progression.
Side effects of Bavencio Injection
- Constipation
- Fatigue
- Musculoskeletal (bone, muscle or joint) pain
- Cough
- Itching
- Infusion site reaction
- Rash
- Decreased appetite
- Urinary tract infection
- High blood pressure
- Mucositis
- Hand-foot syndrome
- Voice change
- Decreased level of thyroid hormones
- Nausea
- Liver toxicity
- Breathlessness
- Abdominal pain
- Headache
- Vomiting
- Diarrhea
How to use Bavencio Injection
How Bavencio Injection works
Quick tips
- Do not receive any immunization or vaccination without your doctor’s approval while taking Bavencio Injection.
- You may be at risk of infection, so try to avoid crowds or people with colds, and immediately report fever or any other signs of infection to your health care provider.
- Inform your doctor immediately if you notice signs or symptoms of skin rash, itchy skin, a rash with tiny spots and bumps, reddening of the skin.
- To reduce nausea, take anti-nausea medications as prescribed by your doctor, and eat small, frequent meals.
- Use contraceptives, and do not conceive a child (get pregnant) while taking Bavencio Injection. Barrier methods of contraception, such as condoms, are recommended.
- Avoid sun exposure. Wear SPF 15 (or higher) sunblock and protective clothing.
- Do not drive or use machines after you have received Bavencio Injection since you might feel tired or dizzy.
Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
Interaction with drugs
Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted) (Injection Route)
Frequently asked questions
Fact Box
Chemical Class
Habit Forming
Therapeutic Class
Action Class
Related lab tests
References
- Avelumab [Prescribing Information]. Boston, MA: EMD Serono, Inc.; 2026. [Accessed 14 Oct. 2026] (online) Available from:
- Bavencio (Avelumab) [Product Information]; 2021. [Accessed 16 Nov. 2022] (online) Available from:
- Avelumab [Prescribing Information]. Rockland, MA: EMD Serono, Inc.; 2022. [Accessed 16 Nov. 2022] (online) Available from:
- Avelumab [Summary of Product Characteristics]. Modugno, Italy: Merck Serono S.p.A.; 2020. [Accessed 16 Nov. 2022] (online) Available from:
- CDSCO: List of new drugs (r-DNA origin) approved for import and marketing in India during Jan, 2020 – June, 2026. [Accessed 14 Oct. 2026] (online) Available from:




Want to know more
We provide you with authentic, trustworthy and relevant informationHave issue with the content
Disclaimer
Marketer details
Address: L-2, J.R. Complex, Gate No. 4, Village Mandoli, Delhi-110 093, India
Vendor Details
Lab tests offered by us
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)















